Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
| ▸ | MLYCD | O95822 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5013465 | 0.75 | ALDH1A1 (0.38) | ALDH1A1 | |
| SCHEMBL990517 | 0.75 | MAPT (0.35) | ALDH1A1 | |
| SCHEMBL7704563 | 0.74 | MLYCD (0.40) | MLYCD | |
| SCHEMBL29129917 | 0.73 | MAPT (0.33) | ALDH1A1 | |
| SCHEMBL28101581 | 0.73 | MAPT (0.33) | ALDH1A1 | |
| SCHEMBL27800543 | 0.73 | MAPT (0.33) | ALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL29053959 | 0.73 | MAPT (0.33) | ALDH1A1 | |
| SCHEMBL886851 | 0.71 | ALDH1A1 (0.44) | ALDH1A1 | |
| SCHEMBL1196853 | 0.70 | MLYCD (0.39) | ALDH1A1PIK3CDMLYCD | |
| SCHEMBL28535905 | 0.70 | ALDH1A1 (0.43) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6361940-B1 | IMMOBILIZATION; GENETIC ENGINEERING | QIAGEN GENOMICS, INC. | 2002-03-26 | — | — | US | claimed |
| US-20250066860-A1 | METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | 2025-02-27 | — | — | US | disclosed |
| US-12195803-B2 | Methods and materials for assessing and treating cancer | THE JOHNS HOPKINS UNIVERSITY (US) | 2025-01-14 | — | — | US | disclosed |
| US-20200377956-A1 | METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER | THE JOHNS HOPKINS UNIVERSITY | 2020-12-03 | — | — | US | disclosed |
| EP-3665308-A1 | METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER | The Johns Hopkins University (US) | 2020-06-17 | — | — | EP | disclosed |
| US-20190256924-A1 | METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER | THE JOHNS HOPKINS UNIVERSITY | 2019-08-22 | — | — | US | disclosed |
| WO-2019067092-A1 | METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER | THE JOHNS HOPKINS UNIVERSITY (US) | 2019-04-04 | — | — | WO | disclosed |
| US-6361940-B1 | IMMOBILIZATION; GENETIC ENGINEERING | QIAGEN GENOMICS, INC. | 2002-03-26 | — | — | US | disclosed |
| EP-0958378-A2 | COMPOSITIONS AND METHODS FOR ENHANCING HYBRIDIZATION SPECIFICITY | Rapigene, Inc. (US) | 1999-11-24 | — | — | EP | disclosed |
| EP-0952228-A2 | Compositions and methods for enhancing hybridization specificity | Rapigene, Inc. (US) | 1999-10-27 | — | — | EP | disclosed |
| WO-1998013527-A2 | COMPOSITIONS AND METHODS FOR ENHANCING HYBRIDIZATION SPECIFICITY | RAPIGENE, INC. (US) | 1998-04-02 | — | — | WO | disclosed |